Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Findings GLP-1 receptor agonists and dual incretin agonists exert their therapeutic effects through multiple mechanisms, including enhancement of glucose-dependent insulin secretion, suppression of glucagon release, appetite reduction, and slowing of gastric emptying
Dead volume in syringes, residual material left in vials, and small measurement errors typically result in 3-8% product waste
Safety and pharmacodynamics of an engineered E
C., Brunengraber, H., Clish, C
About 9 million Americans were taking a GLP-1 drug as of the end of 2022, a Trilliant Health analysis found
Later this summer, BI plans to present data from several large trials of Pradaxa, its oral anticoagulant that reached the European market in March 2008
US$ 27.85
US$ 29.21
US$ 26.94
US$ 25.82
US$ 22.08
US$ 25.27
US$ 26.24
US$ 23.99
